Elanco Animal Health Inc (ELAN)

Precedente Chiudi:

$13.47

Aprire:

$13.73

Volume 24 ore:

3.29M

Capitalizzazione di mercato:

$6.69B

Reddito:

$4.42B

Utile/perdita netta:

$-1.23B

Rapporto P/E:

-67.65

EPS:

-0.2

Flusso di cassa netto:

$117.00M

1 W Prestazione:

+2.04%

1M Prestazione:

-12.31%

6M Prestazione:

+40.79%

1 anno Prestazione:

+48.03%

Intervallo 1D:

$13.41

$13.77

Portata 52W:

$7.88

$16.88

Elanco Animal Health Inc Stock (ELAN) Company Profile

Nome

Elanco Animal Health Inc

Settore

Healthcare (1213)

Industria

Drug Manufacturers - Specialty & Generic (3)

Telefono

877-352-6261

Indirizzo

2500 Innovation Way, Greenfield

Dipendente

5,590

Cinguettio

@Elanco

Prossima data di guadagno

2024-05-30

Ultimi documenti SEC

ELAN's Discussions on Twitter

Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-01-05	Aggiornamento	Stifel	Hold → Buy
2023-12-19	Iniziato	Jefferies	Buy
2023-12-15	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2023-12-07	Iniziato	Exane BNP Paribas	Outperform
2023-04-20	Aggiornamento	Barclays	Equal Weight → Overweight
2022-08-18	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2022-08-16	Downgrade	JP Morgan	Overweight → Neutral
2022-07-21	Downgrade	Goldman	Buy → Sell
2022-07-12	Iniziato	Piper Sandler	Neutral
2021-11-18	Iniziato	Morgan Stanley	Overweight
2021-10-28	Downgrade	Stifel	Buy → Hold
2021-08-05	Ripresa	Credit Suisse	Outperform
2021-06-15	Aggiornamento	Cleveland Research	Underperform → Neutral
2021-05-11	Aggiornamento	Barclays	Underweight → Equal Weight
2021-05-11	Aggiornamento	Gabelli & Co	Hold → Buy
2021-04-15	Iniziato	Stifel	Buy
2021-03-22	Downgrade	Gabelli & Co	Buy → Hold
2021-02-26	Aggiornamento	Credit Suisse	Neutral → Outperform
2020-12-09	Downgrade	Argus	Buy → Hold
2020-11-09	Downgrade	Barclays	Overweight → Underweight
2020-08-20	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-08-13	Ripresa	Credit Suisse	Neutral
2020-08-04	Ripresa	Goldman	Buy
2020-07-27	Downgrade	Cleveland Research	Neutral → Underperform
2020-04-02	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-01-10	Iniziato	Raymond James	Mkt Perform
2019-12-19	Aggiornamento	BofA/Merrill	Neutral → Buy
2019-11-07	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2019-09-23	Iniziato	Barclays	Overweight
2019-08-26	Downgrade	BofA/Merrill	Buy → Neutral
2019-08-15	Aggiornamento	UBS	Sell → Neutral
2019-05-23	Iniziato	Guggenheim	Neutral
2019-03-18	Aggiornamento	BofA/Merrill	Neutral → Buy
2019-03-13	Ripresa	Morgan Stanley	Equal-Weight
2019-02-12	Iniziato	William Blair	Mkt Perform
2019-01-23	Iniziato	UBS	Sell
2019-01-15	Iniziato	Argus	Buy
2018-10-15	Iniziato	Morgan Stanley	Equal-Weight

Mostra tutto

Elanco Animal Health Inc Borsa (ELAN) Ultime notizie

Breaking Down Elanco Animal Health: 6 Analysts Share Their Views

Benzinga

Elanco Animal Health (ELAN) Q4 2023 Earnings Call Transcript

The Motley Fool

Here's What Key Metrics Tell Us About Elanco Animal Health Incorporated (ELAN) Q4 Earnings

Zacks Investment Research

US Stocks Could Pause For Breather After Record Rally: Analyst Says 'No Doubt' That 2024 Shaping Up To 'Best Year Since 1999'

Benzinga

Analysts Estimate U.S. Physical Therapy (USPH) to Report a Decline in Earnings: What to Look Out for

Zacks Investment Research

Elanco Animal Health Incorporated (ELAN) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Zacks Investment Research

Elanco Animal Health Inc Azioni (ELAN) Dati Finanziari

Elanco Animal Health Inc (ELAN) Reddito 2024

Elanco Animal Health Inc (ELAN) Reddito netto 2024

Elanco Animal Health Inc (ELAN) Flusso di cassa 2024

Elanco Animal Health Inc (ELAN) Utile per azione 2024